mlsanityData to 14 Oct 2026

Clinical Trial Information Extraction with BERT

arXiv 2110.10027 ↗First posted 11 Sep 2021q-bio.QM cs.CL cs.LGcited by 8

Not on the map. Why?

Abstract (arXiv)

Natural language processing (NLP) of clinical trial documents can be useful in new trial design. Here we identify entity types relevant to clinical trial design and propose a framework called CT-BERT for information extraction from clinical trial text. We trained named entity recognition (NER) models to extract eligibility criteria entities by fine-tuning a set of pre-trained BERT models. We then compared the performance of CT-BERT with recent baseline methods including attention-based BiLSTM and Criteria2Query. The results demonstrate the superiority of CT-BERT in clinical trial NLP.

Key facts. Cited by 8 papers in the map (data through 14 Oct 2026). Builds on 7 of its 10 references that are in the map. First posted on arXiv 11 Sep 2021.

Builds on

7 of 10 references.

References · 7

  1. 2018BERT: Pre-training of Deep Bidirectional Transformers for Language Understandingcited by 40,399
  2. 2019BioBERT: a pre-trained biomedical language representation model for biomedical text miningcited by 1,947
  3. 2019Publicly Available Clinical BERT Embeddingscited by 1,002
  4. 2019Transfer Learning in Biomedical Natural Language Processing: An Evaluation of BERT and ELMo on Ten Benchmarking Datasetscited by 299
  5. 2021Applications of artificial intelligence in drug development using real-world datacited by 7
  6. 2020Information Extraction of Clinical Trial Eligibility Criteriacited by 6
  7. 2020Attention-Based LSTM Network for COVID-19 Clinical Trial Parsingcited by 5

Built on by

Cited by year (2026 to 14 Oct)

Citing papers per year: 2022: 1; 2023: 0; 2024: 4; 2025: 1; 2026: 2.

8 papers.